Ardelyx, Inc. Gains 38.21%
Thu, Dec 02, 2021 at 05:30 PM
Ardelyx, Inc. (ARDX:NASDAQ) soared at $1.7, a gain of 38.2%. On Wed, Dec 01, 2021, ARDX:NASDAQ hit a New 2-Week High of $1.23. The stock got featured on our News Catalysts scanner on Fri, Nov 12, 2021 at 08:06 AM in the 'EARNINGS' category. From Wed, Nov 17, 2021, the stock recorded 44.44% Up Days and 20.00% Green Days
The stock spiked on Wed, Dec 01, 2021 at $1.66 with a volume of 257M+.
About Ardelyx, Inc. (ARDX:NASDAQ)
Ardelyx Inc is a clinical stage biopharmaceutical company. It engages in the discovery, development and commercialization of non-systemic, molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal and metabolic diseases.
Top 10 Gainers:
- VOSO (VOSO:NASDAQ), 43.95%
- Ardelyx, Inc. (ARDX:NASDAQ), 38.21%
- JWEL (JWEL:NASDAQ), 25.56%
- BRDS (BRDS:NYSE), 22.16%
- BFRI (BFRI:NASDAQ), 21.25%
- Pioneer Power Solutions, Inc. (PPSI:NASDAQ), 19.38%
- LOCL (LOCL:NYSE), 18.81%
- STRN (STRN:NASDAQ), 18.72%
- Tyme Technologies, Inc. (TYME:NASDAQ), 18.57%
- Duluth Holdings Inc. (DLTH:NASDAQ), 18.4%